🔗 Visit the ClinicalTrials.gov page for NCT00415818
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. | Lancet Oncol | 2011 | 2.57 |
| 2 | Gene therapy for lung neoplasms. | Clin Chest Med | 2011 | 0.84 |
| 3 | Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. | J Int AIDS Soc | 2015 | 0.78 |
| 4 | Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion. | Cancer Invest | 2011 | 0.78 |
| 5 | Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial. | PLoS One | 2015 | 0.77 |
| 6 | New clinical advances in immunotherapy for the treatment of solid tumours. | Immunology | 2015 | 0.76 |